ESSA Pharma Inc. — Director's Dealing 2021

Jan 27, 2021

SEC Form 4/A — Form 4/A

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2020-12-11

Reporting Person: Brettman Ari David (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-11	Stock Option (Right to Buy)	$7.00	A	16500	Acquired	2030-12-11	Common Shares (16500)	Direct

Footnotes

F1: Vesting terms have been amended such that 100% of the options vest after 12 months from the date of grant.

F2: The Reporting Person disclaims beneficial ownership of these securities and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. The Reporting Person is an employee of The Blackstone Group Inc. or one of its affiliates ("Blackstone"). Pursuant to arrangements between the Reporting Person and Blackstone, the Reporting Person is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises.